[Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus]. 1992

B Merola, and E Caruso, and G De Chiara, and E Rossi, and S Longobardi, and A Colao, and G Brusco, and G Lombardi, and M Biraghi
Cattedra di Endocrinologia, II Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli.

Intranasal desmopressin represents the treatment of choice in Central Diabetes Insipidus. Nevertheless, this route of administration bears some practical disadvantage, linked to either difficult delivering technique, or the status of nasal mucose. The antidiuretic effectiveness of oral desmopressin has been recently demonstrated, both in experimental animals and in man. In our study we compared oral vs. intranasal desmopressin efficacy in 13 patients affected by Central Diabetes Insipidus. The results show that the peroral administration of Desmopressin at a mean dose of 500-600 micrograms/die determines an antidiuretic effect comparable to that of intranasal route, without affecting body weight, arterial pressure and chemical analysis. Side effects, generally limited to the first week of treatment, were described (nausea, vomiting, headache, dizziness [corrected], bitter taste, epygastralgia, asthenia, epystassis), inducing 4/13 patients to withdrawal the trial.

UI MeSH Term Description Entries
D008297 Male Males
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003894 Deamino Arginine Vasopressin A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR. Desmopressin,Vasopressin, Deamino Arginine,1-Deamino-8-D-arginine Vasopressin,1-Desamino-8-arginine Vasopressin,Adiuretin,Adiuretin SD,Apo-Desmopressin,DDAVP,Desmogalen,Desmopressin Acetate,Desmopressin Monoacetate,Desmopressin Monoacetate, Trihydrate,Desmopressine Ferring,Desmospray,Desmotabs,Minirin,Minurin,Nocutil,Octim,Octostim,Acetate, Desmopressin,Arginine Vasopressin, Deamino,Ferring, Desmopressine,Monoacetate, Desmopressin,Monoacetate, Trihydrate Desmopressin,Trihydrate Desmopressin Monoacetate,Vasopressin, 1-Deamino-8-D-arginine,Vasopressin, 1-Desamino-8-arginine
D003919 Diabetes Insipidus A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.
D004231 Diuresis An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Diureses
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Merola, and E Caruso, and G De Chiara, and E Rossi, and S Longobardi, and A Colao, and G Brusco, and G Lombardi, and M Biraghi
October 1993, Minerva medica,
B Merola, and E Caruso, and G De Chiara, and E Rossi, and S Longobardi, and A Colao, and G Brusco, and G Lombardi, and M Biraghi
March 1986, Archives of disease in childhood,
B Merola, and E Caruso, and G De Chiara, and E Rossi, and S Longobardi, and A Colao, and G Brusco, and G Lombardi, and M Biraghi
November 1997, Acta paediatrica (Oslo, Norway : 1992),
B Merola, and E Caruso, and G De Chiara, and E Rossi, and S Longobardi, and A Colao, and G Brusco, and G Lombardi, and M Biraghi
December 1988, Archives francaises de pediatrie,
B Merola, and E Caruso, and G De Chiara, and E Rossi, and S Longobardi, and A Colao, and G Brusco, and G Lombardi, and M Biraghi
November 1987, Archives of disease in childhood,
B Merola, and E Caruso, and G De Chiara, and E Rossi, and S Longobardi, and A Colao, and G Brusco, and G Lombardi, and M Biraghi
September 2014, Journal of pediatric endocrinology & metabolism : JPEM,
B Merola, and E Caruso, and G De Chiara, and E Rossi, and S Longobardi, and A Colao, and G Brusco, and G Lombardi, and M Biraghi
September 1978, Archives of internal medicine,
B Merola, and E Caruso, and G De Chiara, and E Rossi, and S Longobardi, and A Colao, and G Brusco, and G Lombardi, and M Biraghi
February 2004, Journal of pediatric endocrinology & metabolism : JPEM,
B Merola, and E Caruso, and G De Chiara, and E Rossi, and S Longobardi, and A Colao, and G Brusco, and G Lombardi, and M Biraghi
May 2017, Journal of pediatric endocrinology & metabolism : JPEM,
B Merola, and E Caruso, and G De Chiara, and E Rossi, and S Longobardi, and A Colao, and G Brusco, and G Lombardi, and M Biraghi
December 2021, The Journal of pediatrics,
Copied contents to your clipboard!